June 2014 FDA Recall Drug by Mckesson Packaging Services
D-1483-2014 - Failed Dissolution Specification; at the 12 month time interval.
This Class III drug recall was voluntarily initiated by Mckesson Packaging Services on June 19, 2014 for the product Drug. The FDA reported the reason for recall as failed dissolution specification; at the 12 month time interval.. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1483-2014
Failed Dissolution Specification; at the 12 month time interval.
06-19-2014
08-06-2014
1,511,250 tablets
Recall Profile & Regulatory Data
Class III - is a situation in which use of, or exposure to, a violative product is not likely to cause adverse health consequences.
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Mckesson Packaging Services
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide
04-27-2017
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Aspirin DR Enteric Coated Tablets, USP 325 mg, UD 750 tablets (25x30), Dist. By: McKesson Packaging Services a business unit of McKesson Corporation, concord, NC
Batch or Lot Expiration Information
Lot# Lot 0093943